Akshay Vaishnaw
Director/Board Member en SCHOLAR ROCK HOLDING CORPORATION .
Fortuna: 4 M $ al 31/03/2024
Perfil
El Dr. Akshay K. Vaishnaw es director independiente de Scholar Rock Holding Corp., director independiente de Editas Medicine, Inc. y presidente de investigación y desarrollo de Alnylam Pharmaceuticals, Inc. y miembro del Royal College of Physicians. Forma parte del Consejo de Administración de Scholar Rock Holding Corp., Scholar Rock, Inc. y Editas Medicine, Inc. Anteriormente, el Dr. Vaishnaw trabajó como Director Senior de Medicina Translacional en Biogen Idec, Inc. También formó parte del consejo de administración de Visterra, Inc. Se licenció en la Universidad de Cardiff, se doctoró en la Facultad de Medicina de la Universidad de Cardiff y se doctoró en la Universidad de Londres.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 04/08/2023 | 23 289 ( 0.02% ) | 3 M $ | 31/03/2024 | |
| 21/06/2023 | 9 455 ( 0.01% ) | 167 921 $ | 31/03/2024 | |
EDITAS MEDICINE, INC.
-.--% | 01/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de Akshay Vaishnaw
| Empresas | Cargo | Inicio |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 02/10/2023 |
| EDITAS MEDICINE, INC. | Director/Board Member | 28/07/2016 |
| SCHOLAR ROCK HOLDING CORPORATION | Director/Board Member | 21/05/2019 |
| The Royal College of Physicians | Corporate Officer/Principal | 07/07/2009 |
Scholar Rock, Inc.
 Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Director/Board Member | 01/05/2019 |
Antiguos cargos conocidos de Akshay Vaishnaw.
| Empresas | Cargo | Fin |
|---|---|---|
| VISTERRA INC | Director/Board Member | 01/07/2018 |
| BIOGEN INC. | Corporate Officer/Principal | 01/01/2005 |
Formación de Akshay Vaishnaw.
| University of London | Doctorate Degree |
| University of Cardiff | Undergraduate Degree |
| Cardiff University School of Medicine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| BIOGEN INC. | Health Technology |
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| EDITAS MEDICINE, INC. | Health Technology |
| SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
| Empresas privadas | 2 |
|---|---|
Visterra, Inc.
 Visterra, Inc. Pharmaceuticals: MajorHealth Technology Visterra, Inc. Is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of antibody-based therapies for kidney diseases, and other chronic diseases. It focuses on its research technology platform, HIEROTOPE technology. The company was founded by Alan L. Crane, Kevin J. Bitterman and Ram Sasisekharan on December 20, 2007 and is headquartered in Waltham, MA. | Health Technology |
Scholar Rock, Inc.
Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Akshay Vaishnaw
